发明名称 Conjugates for the treatment of mesothelioma
摘要 The present invention provides conjugates of cytokines and targeting peptides that is able to bind to a receptor expressed on tumor-associated vessels or to a component of the extracellular matrix associated to the tumor vessels, for treatment of malignant pleural mesothelioma. In particular, the invention provides conjugates comprising the cytokine TNF linked to a peptide containing the NGR motif. The invention further provides pharmaceutical compositions comprising such conjugate and pharmaceutical formulations comprising conjugates dissolved in appropriate buffers.
申请公布号 US9068016(B2) 申请公布日期 2015.06.30
申请号 US201313750682 申请日期 2013.01.25
申请人 Molmed S.P.A 发明人 Bordignon Claudio;Lambiase Antonio
分类号 A61K38/19;A61K38/08;A61K38/10;A61K38/12;C07K14/25;C07K7/64;C07K7/06;C07K7/08;C07K14/525;A61K38/20;A61K38/21;A61K47/48 主分类号 A61K38/19
代理机构 McDonnell Boehnen Hulbert & Berghoff LLP 代理人 McDonnell Boehnen Hulbert & Berghoff LLP
主权项 1. A method for treating mesothelioma in a patient comprising administering to a patient suffering from mesothelioma a conjugate comprising a targeting peptide and a cytokine, wherein the targeting peptide is a peptide containing a NGR motif and wherein the cytokine is TNFα.
地址 Milan IT